Key facts
- CITADEL ADVISORS LLC filed SCHEDULE 13G for Veradermics, Incorporated Common Stock, par value $0.00001 per share (the "Shares") (MANE).
- Disclosed ownership: 4.5%.
- Date of event: 30 Apr 2026.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Citadel Advisors LLC | 4.5% | 1,870,775 | 0 | 1,870,775 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Advisors Holdings LP | 4.5% | 1,870,775 | 0 | 1,870,775 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel GP LLC | 4.5% | 1,870,775 | 0 | 1,870,775 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities LLC | 0% | 17 | 0 | 17 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities Group LP | 0% | 17 | 0 | 17 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities GP LLC | 0% | 17 | 0 | 17 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Kenneth Griffin | 4.5% | 1,870,792 | 0 | 1,870,792 | /s/ Seth Levy | Seth Levy, attorney-in-fact* |
CIK / CUSIP context first